In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
The Lancet Infectious Diseases in conversation with
00:00
Advantages and Trade-offs of Platform Trials
Saleha asks about pros and cons; Josh and Steven discuss efficiencies, shared infrastructure, scale, and added complexity and startup time.
Play episode from 04:01
Transcript
